Shaw; Walter A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shaw; Walter A..The latest application filed is for "sphingosine analogs and use thereof against bacterial lung infections".

Company Profile

3.15.23

Shaw; Walter A. - Alabaster AL
SHAW; Walter A. - Rehovot IL
Shaw; Walter A. - Birmingham AL
Shaw; Walter A - Birmingham AL
SHAW; Walter A. - Bimingham AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapies for treating and preventing chronic rhinosinusitis Grant 11,413,297 - Cochrane , et al. August 16, 2	2022-08-16
Sphingosine Analogs And Use Thereof Against Bacterial Lung Infections App 20210275473 - FUTERMAN; Anthony H. ; et al.	2021-09-09
Novel Therapies For Treating And Preventing Chronic Rhinosinusitis App 20200306274 - COCHRANE; Charles G. ; et al.	2020-10-01
Suppression of cytokine release and cytokine storm Grant 10,739,353 - Sordillo , et al. A	2020-08-11
Oral Composition For Delivery Of Drugs And Other Substances App 20200188518 - SHAW; Walter A. ; et al.	2020-06-18
Oral composition for delivery of drugs and other substances Grant 10,463,738 - Shaw , et al. No	2019-11-05
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies Grant 10,258,691 - Helson , et al.	2019-04-16
Disaccharide synthetic lipid compounds and uses thereof Grant 10,143,744 - Shaw , et al. De	2018-12-04
Oral Composition for Delivery of Drugs and Other Substances App 20180064813 - SHAW; Walter A. ; et al.	2018-03-08
Oral composition for delivery of drugs and other substances Grant 9,872,908 - Shaw , et al. January 23, 2	2018-01-23
Disaccharide Synthetic Lipid Compounds And Uses Thereof App 20170349618 - SHAW; Walter A. ; et al.	2017-12-07
Modifications Of Solid 3-sn-phosphoglycerides App 20170281775 - Yesair; David W. ; et al.	2017-10-05
Disaccharide synthetic lipid compounds and uses thereof Grant 9,518,078 - Shaw , et al. December 13, 2	2016-12-13
Novel Compounds App 20160340298 - BURGESS; Stephen W. ; et al.	2016-11-24
Compounds Grant 9,403,760 - Burgess , et al. August 2, 2	2016-08-02
Suppression of Cytokine Release and Cytokine Storm App 20160184330 - Sordillo; Peter P. ; et al.	2016-06-30
Oral Composition for Delivery of Drugs and Other Substances App 20160166699 - SHAW; Walter A. ; et al.	2016-06-16
Disaccharide Synthetic Lipid Compounds and Uses Thereof App 20160136271 - SHAW; Walter A. ; et al.	2016-05-19
Novel Compounds App 20160024001 - BURGESS; Stephen W ; et al.	2016-01-28
Disaccharide synthetic lipid compounds and uses thereof Grant 9,241,988 - Shaw , et al. January 26, 2	2016-01-26
Protective Effect Of Dmpc, Dmpg, Dmpc/dmpg, Egpg, Lysopg And Lysopc Against Drugs That Cause Channelopathies App 20150343063 - Helson; Lawrence ; et al.	2015-12-03
Disaccharide Synthetic Lipid Compounds and Uses Thereof App 20150110854 - Shaw; Walter A ; et al.	2015-04-23
Novel Compounds App 20140275591 - BURGESS; Stephen W ; et al.	2014-09-18
MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES App 20140011891 - Yesair; David W. ; et al.	2014-01-09
Disaccharide Synthetic Lipid Compounds And Uses Thereof App 20130273149 - SHAW; Walter A. ; et al.	2013-10-17
MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES App 20120283218 - Yesair; David W. ; et al.	2012-11-08
Modifications of solid 3-sn-phosphoglycerides Grant 8,222,233 - Yesair , et al. July 17, 2	2012-07-17
Modifications Of Solid 3-sn-phosphoglycerides App 20110190238 - Yesair; David W. ; et al.	2011-08-04
Modifications of solid 3-sn-phosphoglycerides Grant 7,947,306 - Yesair , et al. May 24, 2	2011-05-24
Oral compositions of fenretinide having increased bioavailability and methods of using the same Grant 7,785,621 - Maurer , et al. August 31, 2	2010-08-31
Oral pharmaceutical compositions and methods of using the same Grant 7,780,978 - Maurer , et al. August 24, 2	2010-08-24
Modifications Of Solid 3-sn-phosphoglycerides App 20090017119 - Yesair; David W. ; et al.	2009-01-15
Modification of solid 3-sn-phosphoglycerides Grant 7,407,779 - Yesair , et al. August 5, 2	2008-08-05
Oral pharmaceutical compositions and methods of using the same App 20060008508 - Maurer; Barry J. ; et al.	2006-01-12
Oral compositions having increased bioavailability and methods of using the same App 20050271707 - Maurer, Barry J. ; et al.	2005-12-08
Oral compositions of fenretinide having increased bioavailability and methods of using the same App 20050106216 - Maurer, Barry J. ; et al.	2005-05-19
Modification of solid 3-sn-phosphoglycerides App 20040259837 - Yesair, David W ; et al.	2004-12-23
Cationic polymers for nucleic acid transfection and bioactive agent delivery Grant 5,948,878 - Burgess , et al. September 7, 1	1999-09-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.